Of relevance, tumor microenvironment plays an important role in protecting cancer cells from the anti-tumor activity of BRAF and MEK inhibitors through paradoxic upregulation of signaling pathways and survival factors [30–33]. This evidence concerns the gene MAP2K7 and cancer.